Regulatory pressure and stock valuation drive the breakup
3 Nov 4 6:46 AM · 4d ago · 13 articles · 2 posts · 3 comments · 4 sources · development 3 of 5
Analysts point to mounting FTC and state regulatory scrutiny on PBMs and healthcare consolidation, plus Trump administration plans for new pricing disclosure rules, as background drivers. Mizuho analyst Ann Hynes notes CVS stock trades at 10.8x 2027 earnings versus 15.7x sector average, suggesting separation could unlock shareholder value through multiple expansion.
“I haven't bought anything at my CVS in like 2 years besides prescriptions. They'd are 2-10x more expensive than any other option with all the grab and go crap they carry.”
Prize_Instance_1416, Reddit commenter · reddit ↗David Joyner CVS Health CEOCVS Health Healthcare conglomerate breaking upFederal Trade Commission Regulator
The whole story articlesvideospostscomments the bright band is this development · numbered dots are the others · click one to jump
What was reported 1 claim about this development
-
first by CNN, 4d ago · also CNBC
1 more headline
What people said 4 voices · verbatim
-
CVS Health To Split Into Two Companies, Separating Benefits From Drugstores https://www. forbes.com/sites/brucejapsen/2 026/11/04/cvs-health-to-split-into-two-companies-separating-benefits-from-drugstores/?utm_source=flipboard&utm_medium=activitypub Posted into Health & Wellness @ health-wellness-forbes
-
It’s 2026. Expecting to call a company and speak to someone is ridiculous. No one will go back to that anymore. Use your MyChart app and contact a nurse practitioner thru that
-
I haven’t bought anything at my CVS in like 2 years besides prescriptions. They’d are 2-10x more expensive than any other option with all the grab and go crap they carry.
-
Oh they'll be able to tell patients if their medication can be stocked by the suppliers?
All 5 developments of CVS splits $117B empire into pharmacy and insurance… →
NewswiresRedditGoogle NewsMastodonYouTubeHacker News